Glaxosmithkline Pharmaceuticals has informed that the Board of Directors at its meeting held on 7th January 2021 have approved the following changes in Board of Directors of the Company. Raju Krishnaswamy has resigned has a Director of the Company with effect from 27th January 2021. The Board of Directors of the Company at its meeting held today, has appointed Mark Dawson as a Non - Executive Director of the Company effective 28th January, 2021.
The above information is a part of company’s filings submitted to BSE.
